Relationship of validated psychometric tools to subsequent medical utilization for asthma.
BACKGROUND
Risk stratification is used to identify patients with asthma at increased risk of experiencing morbidity and resource utilization. Validated psychometric tools are infrequently studied sources of data for this purpose.


OBJECTIVE
To evaluate 4 types of validated psychometric tools as predictors for subsequent asthma utilization and determine their clinical usefulness.


METHODS
Eleven hundred patients with active asthma from a Health Maintenance Organization completed surveys that included demographic information and validated psychometric tools measuring generic quality of life (physical and mental components), asthma-specific quality of life, asthma control, and asthma symptom severity. Survey records were linked to administrative data that captured emergency department and hospital care, short-acting beta-agonist, and oral corticosteroid utilization for the year of and the year following the survey. Relationships of survey variables with subsequent utilization were assessed, adjusting for both baseline demographic and asthma utilization factors.


RESULTS
Scores of each psychometric tool were significantly related to subsequent utilization in univariate analyses and after adjusting for baseline utilization and demographic risk factors. Patients with higher scale-defined morbidity were as much as 4 times more likely to have subsequent utilization (sensitivity as high as 58%; specificity as high as 78%). Addition of an asthma-specific tool to either demographic or utilization prediction models added sensitivity (as much as 15%) but did not substantially improve the prediction properties of models containing both demographic and utilization predictors.


CONCLUSIONS
Validated psychometric tools appear useful for asthma risk stratification in individuals and in populations in which both utilization and demographic predictors are not available.
Schatz
Michael
M
Department of Allergy, Kaiser-Permanente Medical Center, San Diego, Calif 92111, USA. michael.x.schatz@kp.org
Mosen
David
D
Apter
Andrea J
AJ
Zeiger
Robert S
RS
Vollmer
William M
WM
Stibolt
Thomas B
TB
Leong
Albin
A
Johnson
Michael S
MS
Mendoza
Guillermo
G
Cook
E Francis
EF
D000293:Adolescent; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data; D005260:Female; D006304:Health Status; D006306:Health Surveys; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D011594:Psychometrics / Q000379:methods; D011788:Quality of Life; D012307:Risk Factors
D018927:Anti-Asthmatic Agents